About CMed Aesthetics ANZ
Australian & New Zealand distributor of CMed Aesthetics S. r. l. (Italy) products including BioRePeelCl3® (fulfilling within Australia & NZ.) and Lumenscens (scheduled for release in early 2024). The BioRePeelCl3® BioReTherapy range represents a new era in professional dermal peel treatments and regenerative aesthetics.
CMed Aesthetics ANZ are committed to the distribution of novel products which advance the field of regenerative aesthetics. Products have been selected after rigorous evaluation, stress testing and review to ensure compliance with Australian conditions and regulations. Product selection criteria involved safety assessment and physical testing for Australia's diverse gene pool including compliance with Australian regulations. BioRePeelCl3® offers a sustainable regenerative aesthetic system which delivers visible short and long-term tangible benefits from the perspective of the client, as well as the practitioner.
Innovators in cosmetic, regenerative aesthetics and dermatology.
CMed Aesthetics Srl is an innovative company in the field of aesthetic cosmetics, regenerative aesthetics and dermatology. Born from the fusion of pharmaceutical and commercial skills, CMed approached the market with two patented cosmetic solutions. CMed basic principles and values unite and define the way CMed Aesthetics Srl works in Italy and all around the world. CMed continue to invest in R&D to advance scientific development through strategic investments - these are the prerequisites for the long-term success of our business.
